V. Lapierre

587 total citations
28 papers, 452 citations indexed

About

V. Lapierre is a scholar working on Hematology, Management of Technology and Innovation and Genetics. According to data from OpenAlex, V. Lapierre has authored 28 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 5 papers in Management of Technology and Innovation and 4 papers in Genetics. Recurrent topics in V. Lapierre's work include Hematopoietic Stem Cell Transplantation (11 papers), Blood donation and transfusion practices (5 papers) and Blood transfusion and management (4 papers). V. Lapierre is often cited by papers focused on Hematopoietic Stem Cell Transplantation (11 papers), Blood donation and transfusion practices (5 papers) and Blood transfusion and management (4 papers). V. Lapierre collaborates with scholars based in France, Germany and Canada. V. Lapierre's co-authors include D. Couanet, J. Lumbroso, Gilles Vassal, E Benhamou, D Valteau-Couanet, Olivier Hartmann, Dominique Valteau‐Couanet, Rafaël Delgado, Pierre Tiberghien and Laurence Brugières and has published in prestigious journals such as Blood, European Journal of Cancer and Journal of Thrombosis and Haemostasis.

In The Last Decade

V. Lapierre

27 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Lapierre France 13 182 154 128 82 77 28 452
Motoaki Chin Japan 16 93 0.5× 99 0.6× 218 1.7× 55 0.7× 86 1.1× 43 540
Gabriel Rivera United States 9 121 0.7× 85 0.6× 122 1.0× 67 0.8× 182 2.4× 16 570
Yasushi Okoshi Japan 14 167 0.9× 70 0.5× 124 1.0× 94 1.1× 55 0.7× 48 558
Yacov Goshen Israel 13 56 0.3× 119 0.8× 162 1.3× 56 0.7× 88 1.1× 18 443
Toshio Shigekiyo Japan 14 275 1.5× 46 0.3× 91 0.7× 121 1.5× 38 0.5× 59 567
G.A. Amos Burke United Kingdom 13 51 0.3× 110 0.7× 141 1.1× 79 1.0× 221 2.9× 37 601
Keiichi Isoyama Japan 15 400 2.2× 35 0.2× 187 1.5× 120 1.5× 99 1.3× 50 705
Atsuo Okamura Japan 14 172 0.9× 43 0.3× 142 1.1× 115 1.4× 187 2.4× 61 577
M Boasson France 12 303 1.7× 36 0.2× 140 1.1× 98 1.2× 185 2.4× 35 547
Zhixia Yue China 12 94 0.5× 127 0.8× 157 1.2× 28 0.3× 117 1.5× 31 438

Countries citing papers authored by V. Lapierre

Since Specialization
Citations

This map shows the geographic impact of V. Lapierre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Lapierre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Lapierre more than expected).

Fields of papers citing papers by V. Lapierre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Lapierre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Lapierre. The network helps show where V. Lapierre may publish in the future.

Co-authorship network of co-authors of V. Lapierre

This figure shows the co-authorship network connecting the top 25 collaborators of V. Lapierre. A scholar is included among the top collaborators of V. Lapierre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Lapierre. V. Lapierre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roy, Anita, Larissa Lordier, Catherine Pioche‐Durieu, et al.. (2016). Uncoupling of the Hippo and Rho pathways allows megakaryocytes to escape the tetraploid checkpoint. Haematologica. 101(12). 1469–1478. 18 indexed citations
2.
Panterne, Béatrice, Fabienne Pouthier, Véronique Decot, et al.. (2010). Contrôle de qualité des greffons de sang placentaire décongelés : résultats d’une étude multicentrique. Transfusion Clinique et Biologique. 17(2). 41–46.
3.
Lapierre, V., JF Rossi, Farhad Heshmati, et al.. (2010). Ancestim (r-metHuSCF) plus filgrastim and/or chemotherapy for mobilization of blood progenitors in 513 poorly mobilizing cancer patients: the French compassionate experience. Bone Marrow Transplantation. 46(7). 936–942. 9 indexed citations
4.
Lemarié, Claude, Benjamin Esterni, Boris Calmels, et al.. (2007). CD34+ progenitors are reproducibly recovered in thawed umbilical grafts, and positively influence haematopoietic reconstitution after transplantation. Bone Marrow Transplantation. 39(8). 453–460. 16 indexed citations
6.
Tramalloni, Dominique, et al.. (2005). Implication du personnel infirmier dans la sécurité transfusionnelle : évaluation des connaissances et de la pratique à l'institut Gustave-Roussy. Transfusion Clinique et Biologique. 12(6). 427–432. 11 indexed citations
7.
Creuzot-Garcher, Catherine P., P.O. Lafontaine, Françoise Brignole‐Baudouin, et al.. (2004). Traitement des syndromes secs graves par sérum autologue. Journal Français d Ophtalmologie. 27(4). 346–351. 13 indexed citations
8.
Tayebi, Hakim, Pierre Tiberghien, Christophe Ferrand, et al.. (2001). Allogeneic peripheral blood stem cell transplantation results in less alteration of early T cell compartment homeostasis than bone marrow transplantation. Bone Marrow Transplantation. 27(2). 167–175. 23 indexed citations
10.
Valteau‐Couanet, Dominique, E Benhamou, Gilles Vassal, et al.. (2000). Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastoma. Bone Marrow Transplantation. 25(9). 937–942. 49 indexed citations
11.
Tramalloni, Dominique, et al.. (2000). Contrôle ultime pré-transfusionnel: évaluation de sept dispositifs. Transfusion Clinique et Biologique. 7(2). 129–139. 3 indexed citations
12.
Elias, Dominique, V. Lapierre, & V. Billard. (2000). Autotransfusion peropératoire par récupération de sang épanché en chirurgie carcinologique. Annales Françaises d Anesthésie et de Réanimation. 19(10). 739–744. 10 indexed citations
13.
Lapierre, V., et al.. (1999). Formation du personnel infirmier d'un établissement de soins sur la sécurité transfusionnelle: utilisation d'un support visuel. Transfusion Clinique et Biologique. 6(4). 263–265. 1 indexed citations
14.
Lapierre, V. & P Hervé. (1999). [Monitoring and secondary effects of transfusion of labile blood products].. PubMed. 28(24). 1327–35. 1 indexed citations
15.
Hervé, P, V. Lapierre, Pascal Morel, & Pierre Tiberghien. (1999). [What present strategies are helpful in improving transfusion safety in France?].. PubMed. 150(8). 623–30. 2 indexed citations
17.
Lapierre, V. & P Hervé. (1999). [Indications and utilization of labile blood products].. PubMed. 28(24). 1321–6. 1 indexed citations
18.
Lapierre, V., et al.. (1999). Pratiques transfusionnelles érythrocytaires après greffe de cellules souches hématopoiétiques allogéniques. Transfusion Clinique et Biologique. 6(2). 148–152. 2 indexed citations
19.
Lucidarme, Nadine, D Valteau-Couanet, Odile Oberlin, et al.. (1998). Phase II study of high-dose thiotepa and hematopoietic stem cell transplantation in children with solid tumors. Bone Marrow Transplantation. 22(6). 535–540. 46 indexed citations
20.
Thuillez, Christian, et al.. (1987). ARTERIAL AND VENOUS EFFECTS OF VERAPAMIL IN NORMAL VOLUNTEERS. Fundamental and Clinical Pharmacology. 1(1). 35–44. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026